Nephrolithiasis is a very common condition, with a prevalence of about 8% in the general population. Genetic as well as environmental factors are thought to contribute to its pathogenesis. Environmental and especially dietary factors are important in primary as well as in secondary prevention. We review the relevant literature of factors associated with an increased risk of stones that might be object of medical prevention for nephrolithiasis.
CroppiEFerraroPMTaddeiLGambaroGPrevalence of renal stones in an Italian urban population: a general practice-based study. Urol Res2012; 40: 517–522.
2.
RamelloAVitaleCMarangellaMEpidemiology of nephrolithiasis. J Nephrol2000; 13Suppl. 3S45–50.
3.
Medina-EscobedoMZaidiMReal-de LeónEOrozco-RivadeneyraS[Urolithiasis prevalence and risk factors in Yucatan, Mexico]. Salud Publica Mex2002; 44: 541–545.
4.
HiattRADalesLGFriedmanGDHunkelerEMFrequency of urolithiasis in a prepaid medical care program. Am J Epidemiol1982; 115: 255–265.
5.
StamatelouKKFrancisMEJonesCANybergLMCurhanGCTime trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int2003; 63: 1817–1823.
6.
LotanYCadedduJARoerhbornCGPakCYPearleMSCost-effectiveness of medical management strategies for nephrolithiasis. J Urol2004; 172: 2275–2281.
7.
PearleMSCalhounEACurhanGCUrologic diseases in America project: urolithiasis. J Urol2005; 173: 848–857.
8.
SaigalCSJoyceGTimilsinaARDirect and indirect costs of nephrolithiasis in an employed population: opportunity for disease management?Kidney Int2005; 68: 1808–1814.
9.
FerraroPMD'AddessiAGambaroGWhen to suspect a genetic disorder in a patient with renal stones, and why. Nephrol Dial Transplant2013; 28: 811–820.
10.
CoeFLParksJHAsplinJRThe pathogenesis and treatment of kidney stones. N Engl J Med1992; 327: 1141–1152.
11.
TaylorENCurhanGCOxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol2007; 18: 2198–2204.
12.
CurhanGCWillettWCRimmEBStampferMJA prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med1993; 328: 833–838.
13.
CurhanGCWillettWCSpeizerFESpiegelmanDStampferMJComparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med1997; 126: 497–504.
14.
HirvonenTPietinenPVirtanenMAlbanesDVirtamoJNutrient intake and use of beverages and the risk of kidney stones among male smokers. Am J Epidemiol1999; 150: 187–194.
15.
CurhanGCWillettWCKnightELStampferMJDietary factors and the risk of incident kidney stones in younger women: Nurses’ Health Study IIArch Intern Med2004; 164: 885–891.
16.
CurhanGCWillettWCSpeizerFEStampferMJIntake of vitamins B6 and C and the risk of kidney stones in women. J Am Soc Nephrol1999; 10: 840–845.
17.
GrasesFGarcia-GonzalezRTorresJJLloberaAEffects of phytic acid on renal stone formation in rats. Scand J Urol Nephrol1998; 32: 261–265.
18.
TaylorENStampferMJCurhanGCDietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol2004; 15: 3225–3232.
19.
TaylorENCurhanGCFructose consumption and the risk of kidney stones. Kidney Int2008; 73: 207–212.
20.
FerraroPMTaylorENGambaroGCurhanGCSoda and other beverages and the risk of kidney stones. Clin J Am Soc Nephrol2013; 8: 1389–1395.
21.
TaylorENFungTTCurhanGCDASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol2009; 20: 2253–2259.
22.
TaylorENStampferMJCurhanGCObesity, weight gain, and the risk of kidney stones. JAMA2005; 293: 455–462.
23.
SorensenMDChiTSharaNMActivity, energy intake, obesity, and the risk of incident kidney stones in postmenopausal women: a report from the Women's Health Initiative. J Am Soc Nephrol2014; 25: 362–369.
24.
HiattRAEttingerBCaanBQuesenberryCPJrDuncanDCitronJTRandomized controlled trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones. Am J Epidemiol1996; 144: 25–33.
25.
BorghiLSchianchiTMeschiTComparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med2002; 346: 77–84.
26.
KocvaraRPlasguraPPetríkALouzenskýGBartoníckováKDvorácekJA prospective study of nonmedical prophylaxis after a first kidney stone. BJU Int1999; 84: 393–398.
27.
DussolBIovannaCRotilyMA randomized trial of low-animal-protein or high-fiber diets for secondary prevention of calcium nephrolithiasis. Nephron Clin Pract2008; 110: c185–194.
28.
BorghiLMeschiTAmatoFBrigantiANovariniAGianniniAUrinary volume, water and recurrences in idiopathic calcium nephrolithiasis: A 5-year randomized prospective study. J Urol1996; 155: 839–843.
29.
ShusterJJenkinsALoganCSoft drink consumption and urinary stone recurrence: A randomized prevention trial. J Clin Epidemiol1992; 45: 911–916.
30.
FinkHAWiltTJEidmanKEMedical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med2013; 158: 535–543.
31.
Raszeja-WanicB[Effect of thiazide preparations on calcium levels in serum and urine]. Pol Tyg Lek1974; 29: 809–810.
32.
ArowojoluOGoldfarbDSTreatment of calcium nephrolithiasis in the patient with hyperuricosuria. J Nephrol2014.
33.
MadoreFStampferMJRimmEBCurhanGCNephrolithiasis and risk of hypertension. Am J Hypertens1998; 11: 46–53.
34.
TaylorENStampferMJCurhanGCDiabetes mellitus and the risk of nephrolithiasis. Kidney Int2005; 68: 1230–1235.
35.
AlexanderRTHemmelgarnBRWiebeNKidney stones and kidney function loss: a cohort study. BMJ2012; 345e5287.
36.
FerraroPMTaylorENEisnerBHHistory of kidney stones and the risk of coronary heart disease. JAMA2013; 310: 408–15.
